Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2025-12-25 @ 4:18 AM
NCT ID: NCT02668120
Eligibility Criteria: Inclusion Criteria: * Patient aged 18 years or more * Having signed a free and informed consent * Enjoying a social security scheme Inclusion criteria for cases: * Patient who gave birth at the Lille University Hospital between 2000 and 2009. * Lesion of intervillositis chronic histiocytic (IHC) diagnosed during histological examination of the placenta. * An alkaline phosphatase assay during pregnancy is available and has been achieved at University Hospital of Lille. * Prior information and not opposition of the patient to the secondary use of data collected in medical file. Inclusion criteria for low-risk pregnancy : * No pathological obstetric history, no current pregnancy complications * Followed antenatal clinics at the Lille University Hospital * A gestational age corresponding to one of the cases (pairing ± 1 week) * No chronic intervillositis after pathological examination of the placenta Inclusion criteria for high-risk pregnancy: * Patient hospitalized in the maternal-fetal pathology of the Lille University Hospital Service * Presence of IUGR, Death in Utero or severe preeclampsia with fetal repercussion * A gestational age corresponding to one of the cases (pairing ± 1 week) * No chronic intervillositis after pathological examination of the placenta Exclusion Criteria: * Twin pregnancy * Liver disease in the interrogation * Lack of consent of the patient * Patient not covered by a social security scheme * Patient minor * Patient under guardianship
Healthy Volunteers: True
Sex: FEMALE
Minimum Age: 18 Years
Study: NCT02668120
Study Brief:
Protocol Section: NCT02668120